Replies to post #577884 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Hyperactive Dendritic Cells and Flaskworks likely also helped substantially, and of course, Direct.

It boggles the mind. This chatty board, and only myself and cut and paste AEKuster, and one post from Biosect, have used the term “hyperactive” in reference to dendritic cells since I found the patent application in December of last year.

I learn more about this board when it goes quiet. :-)

Since that time, NWBO has made patent applications for the technology in several countries. Probably filed in U.S. as well, just not published yet.

[The Danish Dude]

"Why did MRK drop the deal?"

If I recall properly (July 2022), Merck rumored to offer 40B as best and final and Seagan said 'No"

$NWBO

JAMA journal reviewed August 27th.

Merck reported to ... "have lost interest" in Seagen August 26th. pic.twitter.com/OZlWNv8iHy

— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) November 19, 2022

[dennisdave]

so let me get this. Merck dropped a $40B deal with a 2.2B USD revenue company to concentrate at zero in the bank operating on fumes flirting with bankruptcy NWBO, not being prepared to fund NWBO with a lets say peanuts amount of $150 million and by doing so speeding the process up, partnering early with NWBO and 100% preventing the demise of NWBO?

Instate NWBO had to lend $ 11 million with loan and shark against 22%?

alrighty then